Connect with us
[the_ad id="89560"]

COVID-19

Public Health Agency of Canada “not recommending an additional bivalent booster for the general population this spring”

Published

5 minute read

The federal and provincial governments will have to figure out what to do with millions of COVID-19 vaccine boosters now that it appears they’ll go unused.  On Friday, the Public Health Agency of Canada announced through it’s twitter feed that booster shots should now only be considered for Canadians “at high risk of severe illness”.
Those considered at high risk are those over 80 years old, people between 65 and 79 who haven’t contracted COVID-19 yet, residents living in long-term care homes or with other seniors with complex medical needs, and adults 18 and over who are moderately or severely immunocompromised.
The vast majority of Canadians have already been avoiding the booster shots.  Almost 80% of Canadians haven’t taken a booster in the last 6 months.
It’s also been about 6 months since the Public Health Agency of Canada has reported on the likelihood of becoming ill with COVID-19, being hospitalized or dying while vaccinated and boosted. The last report was made public back at the end of September.

 

Below is the statement on the Public Health Agency of Canada website from Friday, March 3:

OVERVIEW

  • On March 3, 2023, the Public Health Agency of Canada (PHAC) released guidance from the National Advisory Committee on Immunization (NACI) on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19. This guidance is based on current evidence, vaccine principles and NACI expert opinion.
  • NACI now recommends that: Starting in the spring of 2023, an additional booster dose may be offered 6 or more months from the last COVID-19 vaccine dose or infection to the following individuals who are at increased risk of severe illness from COVID-19: (Discretionary NACI recommendation)
    • Adults 80 years of age and older
    • Adults 65 to 79 years of age, particularly if they do not have a known history of SARS-CoV-2 infection
    • Adult residents of long-term care homes and other congregate living settings for seniors or those with complex medical care needs
    • Adults 18 years of age and older who are moderately to severely immunocompromised due to an underlying condition or treatment
  • Bivalent Omicron-targeting mRNA COVID-19 vaccines continue to be the preferred booster products.
  • Individuals who have not received previously recommended doses, including a primary series or fall 2022 booster dose, are recommended to receive them now. For more information, please refer to Guidance on COVID-19 vaccine booster doses: Initial considerations for 2023.

QUOTES

“Bivalent booster dose uptake is still relatively low among the populations at risk of severe disease, and we hope to see this improve. Older adults, particularly those over 80 years, consistently have the highest risk of severe disease, especially if they are unvaccinated. We have historically seen patterns of waning protection against severe disease by 6 months after the last dose, particularly in older adults without prior infection. Because of this, as a precautionary measure, NACI is recommending this spring that an additional bivalent booster dose may be offered after 6 months for those at highest risk of severe disease, including older adults and persons who are moderately to severely immunocompromised. There may be a broader program in fall of 2023, depending on COVID-19 epidemiology.”

– Dr. Shelley Deeks, NACI Chair

“It remains important to stay up to date with your COVID-19 vaccines, including recommended booster doses, given the continued circulation of SARS-CoV-2 virus variants in Canada and elsewhere. Booster doses help to build back protection against severe disease that wanes over time after COVID-19 vaccination or infections. Given the current COVID-19 epidemiology, including the relatively stable disease activity we have observed in recent months, and generally high levels of antibodies against COVID-19 from vaccines and/or infection among Canadians, NACI is currently not recommending an additional bivalent booster for the general population this spring. However, individuals at highest risk of getting severely ill from COVID-19, including older adults and individuals considered immunocompromised, may be offered a spring bivalent booster dose. Regardless of risk factors, I encourage anyone who has not yet received their primary series or their fall 2022 bivalent booster to get these vaccinations now to reduce their risk of severe outcomes of COVID-19, including hospitalization.”

– Dr. Theresa Tam, Chief Public Health Officer

 

After 15 years as a TV reporter with Global and CBC and as news director of RDTV in Red Deer, Duane set out on his own 2008 as a visual storyteller. During this period, he became fascinated with a burgeoning online world and how it could better serve local communities. This fascination led to Todayville, launched in 2016.

Follow Author

COVID-19

Trump DOJ seeks to quash Pfizer whistleblower’s lawsuit over COVID shots

Published on

From LifeSiteNews

By Calvin Freiburger

The Justice Department attorney did not mention the Trump FDA’s recent admission linking the COVID shots to at least 10 child deaths so far.

The Trump Department of Justice (DOJ) is attempting to dismiss a whistleblower case against Pfizer over its COVID-19 shots, even as the Trump Food & Drug Administration (FDA) is beginning to admit their culpability in children’ s deaths.

As previously covered by LifeSiteNews, in 2021 the BMJ published a report on insider information from a former regional director of the medical research company Ventavia, which Pfizer hired in 2020 to conduct research for the company’s mRNA-based COVID-19 shot.

The regional director, Brook Jackson, sent BMJ “dozens of internal company documents, photos, audio recordings, and emails,” which “revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety […] We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA did not inspect Ventavia’s trial sites.”

According to the report, Ventavia “falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial.” Overwhelmed by numerous problems with the trial data, Jackson filed an official complaint with the FDA.

Jackson was fired the same day, and Ventavia later claimed that Jackson did not work on the Pfizer COVID-19 shot trial; but Jackson produced documents proving she had been invited to the Pfizer trial team and given access codes to software relating to the trial. Jackson filed a lawsuit against Pfizer for violating the federal False Claims Act and other regulations in January 2021, which was sealed until February 2022. That case has been ongoing ever since.

Last August, U.S. District Judge Michael Truncale dismissed most of Jackson’s claims with prejudice, meaning they could not be refiled. Jackson challenged the decision, but the Trump DOJ has argued in court to uphold it, Just the News reports, with DOJ attorney Nicole Smith arguing that the case concerns preserving the government’s unfettered power to dismiss whistleblower cases.

The rationale echoes a recurring trend in DOJ strategy that Politico described in May as “preserving executive power and preventing courts from second-guessing agency decisions,” even in cases that involve “backing policies favored by Democrats.”

Jackson’s attorney Warner Mendenhall responded that the administration “really sort of made our case for us” in effectively admitting that DOJ is taking the Fair Claims Act’s “good cause” standard for state intervention to mean “mere desire to dismiss,” which infringes on his client’s “First Amendment right to access the courts, to vindicate what she learned.”

Mendenhall added that in a refiled case, Jackson “may be able to bring a very different case along the same lines, but with the additional information” to prove fraud, whereas rejection would send the message that “if fraud involves government complicity, don’t bother reporting it.”

“The truth is we do not know if we saved lives on balance,” admitted FDA Chief Medical Officer Vinay Prasad in a recent leaked email. “It is horrifying to consider that the U.S. vaccine regulation, including our actions, may have harmed more children than we saved. This requires humility and introspection.”

The COVID shots have been highly controversial ever since the first Trump administration’s Operation Warp Speed initiative prepared and released them in a fraction of the time any previous vaccine had ever been developed and tested. As LifeSiteNews has extensively covered, a large body of evidence has steadily accumulated over the past five years indicating that the COVID jabs failed to prevent transmission and, more importantly, carried severe risks of their own.

Ever since, many have intently watched and hotly debated what President Donald Trump would do about the situation upon his return to office. Though he never backed mandates like former President Joe Biden did, for years Trump refused to disavow the shots to the chagrin of his base, seeing Operation Warp Speed as one of his crowning achievements. At the same time, during his latest run he embraced the “Make America Healthy Again” movement and its suspicion of the medical establishment more broadly.

So far, Trump’s second administration has rolled back several recommendations for the shots but not yet pulled them from the market, despite hiring several vocal critics of the COVID establishment and putting the Department of Health & Human Services under the leadership of America’s most prominent anti-vaccine advocate, Robert F. Kennedy Jr. Most recently, the administration has settled on leaving the current jabs optional but not supporting work to develop successors.

In a July interview, FDA Commissioner Marty Makary asked for patience from those unsatisfied by the administration’s handling of the shots, insisting more time was needed for comprehensive trials to get more definitive data.

Continue Reading

COVID-19

Canadian Health Department funds study to determine effects of COVID lockdowns on children

Published on

From LifeSiteNews

By Anthony Murdoch

The commissioned study will assess the impact on kids’ mental well-being of COVID lockdowns and ‘remote’ school classes that banned outdoor play and in-person learning.

Canada’s Department of Health has commissioned research to study the impact of outdoor play on kids’ mental well-being in light of COVID lockdowns and “remote” school classes that, for a time, banned outdoor play and in-person learning throughout most of the nation. 

In a notice to consultants titled “Systematic Literature Reviews And Meta Analyses Supporting Two Projects On Children’s Health And Covid-19,” the Department of Health admitted that “Exposure to green space has been consistently associated with protective effects on children’s physical and mental health.”

A final report, which is due in 2026, will provide “Health Canada with a comprehensive assessment of current evidence, identify key knowledge gaps and inform surveillance and policy planning for future pandemics and other public health emergencies.”

Bruce Squires, president of McMaster Children’s Hospital of Hamilton, Ontario, noted in 2022 that “Canada’s children and youth have borne the brunt” of COVID lockdowns.

From about March 2020 to mid-2022, most of Canada was under various COVID-19 mandates and lockdowns, including mask mandates, at the local, provincial, and federal levels. Schools were shut down, parks were closed, and most kids’ sports were cancelled. 

Mandatory facemask polices were common in Canada and all over the world for years during the COVID crisis despite over 170 studies showing they were not effective in stopping the spread of COVID and were, in fact, harmful, especially to children.

In October 2021, then-Prime Minister Justin Trudeau announced unprecedented COVID-19 jab mandates for all federal workers and those in the transportation sector, saying the un-jabbed would no longer be able to travel by air, boat, or train, both domestically and internationally.

As reported by LifeSiteNews, a new report released by the Justice Centre for Constitutional Freedoms (JCCF) raised alarm bells over the “harms caused” by COVID-19 lockdowns and injections imposed by various levels of government as well as a rise in unexplained deaths and bloated COVID-19 death statistics.

Indeed, a recent study showed that COVID masking policies left children less able to differentiate people’s emotions behind facial expressions.

Continue Reading

Trending

X